Thomas Lynch
@Qvidtvm Management Llc
Latest period2024 - Q3ReportedManaged Assets$142.873MTotal holdings8
Assets growth rate14.27%Assets growth rate (2-Q avg)7.47%Continuous growth in asset value3 quarters
Portfolio positions
This chart displays the top 10 holdings in Qvidtvm Management Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 8 positions.
Assets under management
The assets under management (AUM) of Qvidtvm Management Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 3 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 142.873M in assets, with a quarterly growth rate of 14.27% and a 2-quarter average growth rate of 7.47%. The portfolio is managed by Thomas Lynch, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
BIOBio Rad Labs Inc
| 29.5% | $42.136M 125,938 shares@ $334.58 avg price | |
SOLVSolventum Corp
| 24.27% | $34.67M 497,276 shares@ $69.73 avg price | Increased 13.48% |
WABWabtec
| 13.81% | $19.718M 108,475 shares@ $181.78 avg price | Decreased -4.82% |
RTORentokil Initial Plc
| 13.09% | $18.702M 750,176 shares@ $24.94 avg price | Decreased -15.59% |
XRAYDentsply Sirona Inc
| 8.7% | $12.417M 458,866 shares@ $27.07 avg price | Increased 75.77% |
BRCCBrc Inc
| 7.71% | $11.012M 3.22M shares@ $3.42 avg price | Increased 24.22% |
ZGNErmenegildo Zegna N V Ord Shs
| 2.04% | $2.908M 295,562 shares@ $9.84 avg price | New Position |
OMICSingular Genomics Systems Inc
| 0.92% | $1.309M 83,558 shares@ $15.68 avg price |